Granisetron Hydrochloride Syrup – GRANIVEX Drops

Description

GRANIVEX Drops is an oral liquid formulation of Granisetron Hydrochloride Syrup, a selective serotonin (5-HT3) receptor antagonist used for the prevention and treatment of nausea and vomiting. It is commonly indicated in chemotherapy, radiotherapy, and post-operative settings where control of emesis is required.

Key Points

Selective Anti-Emetic Action – Works by blocking serotonin (5-HT3) receptors in the central nervous system and gastrointestinal tract, helping prevent nausea and vomiting.

Effective in Multiple Clinical Settings – Provides control of emesis in Chemotherapy-induced nausea and vomiting, Radiotherapy-induced nausea and vomiting, and Post-operative nausea and vomiting.

Pediatric-Friendly Oral Formulation – Available as drops/syrup, making it suitable where oral liquid dosing is preferred, especially in pediatric and non-IV settings.

Well-Established Safety Profile – Generally well tolerated when used as prescribed; common effects may include headache, constipation, dizziness, and fatigue.

Targeted Specialities
Medical Oncology
Radiation Oncology
Anesthesiology
Pediatrics
General Medicine
Surgical Specialties

Disclaimer
To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.